BI-2536
Quick Overview for BI-2536 (ABIN7233234)
Application
Chemical Name
-
-
Purpose
- Dual Plk/BRD4 inhibitor, Destabilizes Myc
-
Characteristics
- BI 2536 was originally reported as a potent (IC50's Plk1 = 0.83nM, Plk2 = 3.5nM and Plk3 = 9.0nM) and selective2 Polo-like kinase inhibitor (IC50's Plk1 = 0.83nM, Plk2 = 3.5nM and Plk3 = 9.0nM) that caused mitotic arrest and apoptosis induction in various human cancer cell lines. It was later found to be a potent inhibitor (IC50 = 100nM) of BET family member BRD4 and able to potently suppress c-Myc expression in MM.1S multiple myeloma cells. BI 2536 destabilizes N-Myc by inhibiting the deactivation of the ubiquitin E3 ligase Fbw7 by Plk1.
-
Purity
- >97 %
-
Formula
- C28H39N7O3
-
Solubility
- Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 25 mg/ml)
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Powder
-
Storage
- -20 °C
-
-
-
Background
- Apoptosis inducer,Epigenetics,Cell cycle,Myc,Bromodomain,Ubiquitin/Proteasome,Cell death,Cancer,Posttranslational modification,Chromatin
-
Molecular Weight
- 521.67
-
CAS-No
- 755038-02-9
-
-